image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Brickability

June 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BRCK
  • Price:
  • 88.5p
Amazingly, Brickability has guided forecasts upwards for the THIRD time since last June after saying that following a very strong Q4, it now expects to report revenues of £520m.  Cenkos has immediately upgraded pretax profit forecasts for FY’22 from £28.6m to £34.1m for new eps of 9.6p. For FY’23 it expects pretax profit of £36.9m (from £35.4m) for new eps of 9.9p (9.5p).Meanwhile, its acquisition pipeline remains strong with the group “assessing a number of potential opportunities.” I originally highlighted the shares at 60p in April ‘20 and again just last month. With Cenkos saying fair value is 136p, there’s plenty to go for.  I am a buyer.  ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X